Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA NATCO PHARMA CIPLA/
NATCO PHARMA
 
P/E (TTM) x 33.8 25.9 130.3% View Chart
P/BV x 4.3 2.5 173.1% View Chart
Dividend Yield % 0.5 0.8 58.1%  

Financials

 CIPLA   NATCO PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
NATCO PHARMA
Mar-22
CIPLA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0831,189 91.1%   
Low Rs806750 107.4%   
Sales per share (Unadj.) Rs269.7106.6 253.2%  
Earnings per share (Unadj.) Rs31.79.3 340.6%  
Cash flow per share (Unadj.) Rs44.817.1 261.4%  
Dividends per share (Unadj.) Rs5.004.50 111.1%  
Avg Dividend yield %0.50.5 114.1%  
Book value per share (Unadj.) Rs257.8233.4 110.4%  
Shares outstanding (eoy) m806.81182.52 442.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.59.1 38.5%   
Avg P/E ratio x29.8104.1 28.6%  
P/CF ratio (eoy) x21.156.6 37.3%  
Price / Book Value ratio x3.74.2 88.2%  
Dividend payout %15.848.3 32.6%   
Avg Mkt Cap Rs m762,177176,990 430.6%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2994,448 793.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,63319,448 1,119.1%  
Other income Rs m3,217990 325.0%   
Total revenues Rs m220,85120,438 1,080.6%   
Gross profit Rs m43,2982,635 1,643.2%  
Depreciation Rs m10,5201,426 737.7%   
Interest Rs m1,064177 600.8%   
Profit before tax Rs m34,9332,022 1,727.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,338322 2,900.0%   
Profit after tax Rs m25,5951,700 1,505.6%  
Gross profit margin %19.913.5 146.8%  
Effective tax rate %26.715.9 167.9%   
Net profit margin %11.88.7 134.5%  
BALANCE SHEET DATA
Current assets Rs m147,10824,972 589.1%   
Current liabilities Rs m49,1297,104 691.6%   
Net working cap to sales %45.091.9 49.0%  
Current ratio x3.03.5 85.2%  
Inventory Days Days6370 89.5%  
Debtors Days Days6116 4.9%  
Net fixed assets Rs m119,41526,119 457.2%   
Share capital Rs m1,614365 442.1%   
"Free" reserves Rs m206,36442,237 488.6%   
Net worth Rs m207,97742,602 488.2%   
Long term debt Rs m4,1620-   
Total assets Rs m266,52351,091 521.7%  
Interest coverage x33.812.4 272.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.4 214.5%   
Return on assets %10.03.7 272.3%  
Return on equity %12.34.0 308.4%  
Return on capital %17.05.2 328.7%  
Exports to sales %26.20-   
Imports to sales %8.220.0 41.0%   
Exports (fob) Rs m57,094NA-   
Imports (cif) Rs m17,8033,882 458.6%   
Fx inflow Rs m60,1808,881 677.6%   
Fx outflow Rs m17,8033,882 458.6%   
Net fx Rs m42,3764,999 847.7%   
CASH FLOW
From Operations Rs m33,259465 7,152.5%  
From Investments Rs m-18,719-53 35,318.5%  
From Financial Activity Rs m-15,998348 -4,597.1%  
Net Cashflow Rs m-1,323853 -155.1%  

Share Holding

Indian Promoters % 13.5 48.8 27.6%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 26.0 190.1%  
FIIs % 27.7 11.7 237.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 51.2 129.7%  
Shareholders   388,864 121,336 320.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Cipla vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Natco Pharma Share Price Performance

Period Cipla Natco Pharma S&P BSE HEALTHCARE
1-Day -1.74% 0.16% -0.45%
1-Month -4.68% -8.21% -2.34%
1-Year 19.92% -31.17% -5.95%
3-Year CAGR 33.51% -0.58% 20.82%
5-Year CAGR 13.17% -9.30% 11.40%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Natco Pharma the stake stands at 48.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Natco Pharma paid Rs 4.5, and its dividend payout ratio stood at 48.3%.

You may visit here to review the dividend history of Cipla, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.